Table 1.
Transplantation parameters and follow-up characteristics of animals included in this study
| Sex | CD34+ transplant dose (million) | CD34+ transplant dose per kg (million) | % GFP+ infused cells | Infused GFP+ cells (million) | Follow-up time points (months after TBI) | Symbol on graphs | |
|---|---|---|---|---|---|---|---|
| JM82, TBI | M | 91 | 7.2 | 34% | 30.6 | 1, 12, 29, 45.5, 47, 48, and 49 months |  |
| ZK22, TBI | M | 82 | 7.2 | 31% | 25.2 | 2, 12.5, 29.5, 45, 62, and 63 months |  |
| ZJ31, TBI | M | 23 | 4.1 | 35% | 8.0 | 2, 35, 63, 73.5, 75, and 76 months |  |
| ZG66, TBI | F | 48 | 8.5 | 35% | 16.7 | 1, 36, 76, 104, and 106 months |  |
| 4016 | M | NA | NA | NA | NA | NA | |
| DBv1 | M | NA | NA | NA | NA | NA | |
| F64 | F | NA | NA | NA | NA | NA | |
| DHA3 | M | NA | NA | NA | NA | NA | |
| DHG6 | M | NA | NA | NA | NA | NA | |
| 0L4 | M | NA | NA | NA | NA | NA | |
| 06M | M | NA | NA | NA | NA | NA | |
| DGMH | M | NA | NA | NA | NA | NA |
| Sex | CD34+ transplant dose (million) | CD34+ transplant dose per kg (million) | % GFP+ infused cells | Infused GFP+ cells (million) | Follow-up time points (months after TBI) | Symbol on graphs | |
|---|---|---|---|---|---|---|---|
| JM82, TBI | M | 91 | 7.2 | 34% | 30.6 | 1, 12, 29, 45.5, 47, 48, and 49 months | |
| ZK22, TBI | M | 82 | 7.2 | 31% | 25.2 | 2, 12.5, 29.5, 45, 62, and 63 months | |
| ZJ31, TBI | M | 23 | 4.1 | 35% | 8.0 | 2, 35, 63, 73.5, 75, and 76 months | |
| ZG66, TBI | F | 48 | 8.5 | 35% | 16.7 | 1, 36, 76, 104, and 106 months | |
| 4016 | M | NA | NA | NA | NA | NA | |
| DBv1 | M | NA | NA | NA | NA | NA | |
| F64 | F | NA | NA | NA | NA | NA | |
| DHA3 | M | NA | NA | NA | NA | NA | |
| DHG6 | M | NA | NA | NA | NA | NA | |
| 0L4 | M | NA | NA | NA | NA | NA | |
| 06M | M | NA | NA | NA | NA | NA | |
| DGMH | M | NA | NA | NA | NA | NA |
Details of transplantation and the clonal patterns in nonerythroid lineages from animals JM82, ZG66, ZJ31, and ZK22 have been previously reported. (PMC6794559, PMC7393805, PMC5356453, and PMC3979461, respectively).
F, female; M, male; NA, not applicable.